Frequency of tuberculosis in psoriasis patients using anti-TNF therapy during 16 years of follow-up
We concluded that psoriasis patients receiving TNF inhibitor therapy are at risk of tuberculosis infection despite isoniazid prophylaxis and contrary to the literature it looks like those patients treated with etanercept may be at greater risk for tuberculosis than patients treated with other TNF inhibitor agents.
Authors
- Nahide Onsun (ORCID: https://orcid.org/0000-0001-6259-0219)
- Ömer Mert (ORCID: https://orcid.org/0000-0002-4509-1167)
- Begüm Güneş (ORCID: https://orcid.org/0000-0001-6122-0646)
- Bahar Güler Filiz (ORCID: https://orcid.org/0000-0001-6534-1058)
Institutions
- Ministry of Health (TR)
- Biruni University (TR)
- Sivas State Hospital (TR)
- Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Advances in Dermatology and Allergology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/ada.2025.152059
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.40